← Leaderboards
Daniel R Meldrum
Indiana Univ-Purdue Univ At Indianapolis
$3,269,550
Attributed
$3,269,550
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $752.7K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$3,269,550 · 2
By mechanism
R01$3,269,550 · 2
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Kirstan K Meldrum$2,261,885
- David B Donner$2,649,635
- Jamie L Renbarger$11,642,876
- Barbara Kluve-Beckerman$1,597,288
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisMaleCountryResistanceProteinsMyocardial IschemiaIschemiaMediatingProductionReperfusion InjuryFemaleAnimalsProgramsMyocardiumMyocardialInjurySignal TransductionBiological AvailabilityBaseAblationBackCessation Of LifeEstrogensEstrogen Receptor 2
Grant awards (9)
TNRF1 Signaling Resistance in Ischemic Human Female Myocardium$449,932
R01 · FY2010 · HL · contact PI
TNRF1 Signaling Resistance in Ischemic Human Female Myocardium$445,740
R01 · FY2009 · HL · contact PI
TNRF1 Signaling Resistance in Ischemic Human Female Myocardium$467,297
R01 · FY2008 · HL · contact PI
Progenitor cell pretreatment against acute surgical I/R$285,403
R01 · FY2008 · GM · contact PI
TNFR1 Signaling Resistance in Ischemic Human Female Myocardium$439,848
R01 · FY2007 · HL · contact PI
Progenitor cell pretreatment against acute surgical I/R$285,403
R01 · FY2007 · GM · contact PI
Progenitor cell pretreatment against acute surgical I/R$293,927
R01 · FY2006 · GM · contact PI
Progenitor cell pretreatment against acute surgical I/R$301,000
R01 · FY2005 · GM
Progenitor cell pretreatment against acute surgical I/R$301,000
R01 · FY2004 · GM